Lifeward (LFWD) Revenue Growth (3y) (2018 - 2026)
Lifeward (LFWD) Revenue Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 17.14% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.73% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.92% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | 47.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.20% |
| Dec 31, 2025 | 32.61% |
| Sep 30, 2025 | 91.22% |
| Jun 30, 2025 | 53.91% |
| Mar 31, 2025 | 79.12% |
| Dec 31, 2024 | 82.46% |
| Sep 30, 2024 | 45.93% |
| Jun 30, 2024 | 67.16% |
| Mar 31, 2024 | 58.93% |
| Dec 31, 2023 | 78.13% |
| Sep 30, 2023 | 80.64% |
| Jun 30, 2023 | -7.11% |
| Mar 31, 2023 | 17.41% |
| Dec 31, 2022 | 22.65% |
| Sep 30, 2022 | -10.46% |
| Jun 30, 2022 | 21.42% |
| Mar 31, 2022 | -17.87% |
| Dec 31, 2021 | -7.69% |
| Sep 30, 2021 | 6.84% |
| Jun 30, 2021 | -6.73% |